Plain-English translation of NCT01965132 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →This is a registry study — meaning researchers are collecting real-world information from patients who are already taking medications for their arthritis. Rather than testing a new drug in a controlled trial, this study follows patients as they receive their regular medical care and documents how these medications work, what side effects occur, and how well the treatment helps over time.
Doctors need to understand how these medications perform in everyday practice across different patients and situations. This information helps rheumatologists make better decisions about which treatment is right for each person.
You likely qualify if…
You likely don't qualify if…
You will continue your regular appointments with your rheumatologist and take your medication exactly as prescribed — nothing changes about your treatment. Researchers will simply gather information from your routine visits and lab tests to see how well the medication is working for you. There are no extra visits, tests, or procedures required beyond your normal care.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
South Korea
Seoul National University Hospital
Enrollment target
~10,000 participants
Started
December 2012
Primary completion
December 2029
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kichul Shin, MD
SMG-SNU Boramae Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.